Summary

• LENSAR has shown strong technical buy signals, high Weighted Alpha, and consistent price appreciation, gaining 16.65% since the Trend Seeker buy signal on 2/28..
• The company specializes in femtosecond laser systems for cataract treatment, with notable products like the LENSAR Laser System and ALLY Adaptive Cataract Treatment System..
• Key technical indicators include 100% technical buy signals, a 252.67% gain in the last year, and trading above its 20, 50, and 100-day moving averages..
• Fundamental factors are strong, with expected revenue growth of 27.37% this year and 29.37% next year, and earnings projected to increase significantly.

The Chart of the Day belongs to the  femtosecond laser system company LENSAR (LNSR). I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart feature to review the charts for consistent price appreciation. Since the Trend Seeker signaled a buy on 2/28 the stock gained 16.65%.

LNSR Price vs Daily Moving Averages:

(Click on image to enlarge)

LNSR (Barchart)

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida. 

Barchart's Opinion Trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 20 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report.

Barchart Technical Indicators:

• 100% technical buy signals
• 229.51+ Weighted Alpha
• 252.67% gain in the last year
• .62 - 60 month Beta
• Trend Seeker buy signal
• Above its 20, 50 and 100 day moving averages
• 7 new highs and up 30.85% in the last month
• Relative Strength Index 78.60%
• Technical support level at $12.64
• Recently traded at $15.34 with 50 day moving average of $9.84

Fundamental Factors:

• Market Cap $164 million
• Revenue expected to grow 27.37% this year and another 29.37% next year
• Earnings estimated to increase 6.40% this year and an additional 103.92% next year

Analysts and Investor Sentiment -- I don't buy stocks because everyone else is buying but I do realize that if major firms and investors are dumping a stock it's hard to make money swimming against the tide:

• Wall Street analysts issued 2 strong buy opinions on the stock with price targets between $15 and $16
• CFRAs MarketScope rates the stock a hold
• MorningStar thinks the stock is 15% over valued
• 1,140 investors monitor the stock on Seeking Alpha and rates it the #1 Healthcare Equipment company

More By This Author:

Elbit Systems - Leader In Aerospace & Defense Solutions
Brown & Brown Insurance Leader
Coastal Financial Hits A String Of All Time Highs